Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
12 results loaded, newest first. End of these results. The latest changes are still being indexed. Try again shortly for updated results.
F N B (NYSE: FNB ) reported third-quarter financial results on Tuesday. The transcript from the company's third-quarter earnings call has been provided below. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. View the webcast at Summary F N B Corporatio
AEye (NASDAQ: LIDR ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary AEye Inc reported signifi
Bain Capital Private Credit said it entered into indentures related to a private placement of $350 million of 7.600% notes due 2031. The company said the transaction closed on October 8 and the notes mature on October 8, 2031.
Silver Bow Mining said it entered into a note purchase agreement for a $5.0 million secured promissory note with Ocean Partners UK Limited. The note matures on March 31, 2027 and carries interest at 12-month SOFR plus 6.75%.
Stoke Therapeutics announced two presentations of data for STK-002, an investigational medicine targeting Autosomal Dominant Optic Atrophy (ADOA), at the American Academy of Ophthalmology (AAO) 2026 Annual Meeting. The company also provided an update on its Phase 1 OSPREY study, with initial safety and efficacy data an
Formycon AG is incorporating AI and digital technologies into its biosimilar development processes, aiming to optimize workflows and create sustainable value. The company is implementing PhlexTMF Enterprise, an electronic trial master file solution with AI-assisted capabilities, and an AI-powered software for analyzing
The EPCORE DLBCL-2 trial showed that epcoritamab combined with R-CHOP reduced the risk of disease progression or death by 51% compared to R-CHOP alone in newly diagnosed diffuse large B-cell lymphoma patients.
Amylyx Pharma (NASDAQ: AMLX ) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. This transcript is brought to you APIs. For real-time access to our entire catalog, please visit for a consultation. The full earnings call is available at Summary Amylyx Pharma re
On Wednesday, GRAIL (NASDAQ: GRAL ) discussed second-quarter financial results during its earnings call. The full transcript is provided below. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary GRAIL reported a strong second quarter 2026
Dr Reddy's Laboratories (NYSE: RDY ) held its first-quarter earnings conference call on Wednesday. Below is the complete transcript from the call. This content is powered APIs. For comprehensive financial data and transcripts, visit The full earnings call is available at Summary Dr Reddy's Laboratories reported a 5.6%
Outlook Therapeutics said it released third-quarter fiscal 2026 results and hosted a call, while management highlighted FDA approval of Lytenava for wet AMD in the U.S.
First United Corp submits regulatory filing with the SEC. The filing is available for public review.